OPRX

SEC source: 0001628280-25-044540 · wk-form4_1759873941.xml · derivative · entry 3

Besch Doug · CIK 0001947731 · Chief Product & Tech Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,325 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F3 · derivative.exercise_date: The restricted stock units vest in three equal annual installments beginning October 3, 2023, the first anniversary of the grant date.

F3 · derivative.expiration_date: The restricted stock units vest in three equal annual installments beginning October 3, 2023, the first anniversary of the grant date.

SEC source: 0001628280-25-044540 · wk-form4_1759873941.xml · nonDerivative · entry 2

Besch Doug · CIK 0001947731 · Chief Product & Tech Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 69,572

F2 · shares: These shares were withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended.

SEC source: 0001628280-25-044540 · wk-form4_1759873941.xml · nonDerivative · entry 1

Besch Doug · CIK 0001947731 · Chief Product & Tech Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 70,555

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

SEC source: 0001628280-25-044549 · wk-form4_1759877172.xml · derivative · entry 3

Odence-Ford Marion · CIK 0001845002 · Chief Legal & Admin Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,649 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F3 · derivative.exercise_date: The restricted stock units vest in three equal annual installments beginning October 3, 2023, the first anniversary of the grant date.

F3 · derivative.expiration_date: The restricted stock units vest in three equal annual installments beginning October 3, 2023, the first anniversary of the grant date.

SEC source: 0001628280-25-044549 · wk-form4_1759877172.xml · nonDerivative · entry 2

Odence-Ford Marion · CIK 0001845002 · Chief Legal & Admin Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 90,598

F2 · shares: These shares were withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended.

SEC source: 0001628280-25-044549 · wk-form4_1759877172.xml · nonDerivative · entry 1

Odence-Ford Marion · CIK 0001845002 · Chief Legal & Admin Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 92,550

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

SEC source: 0001628280-25-044543 · wk-form4_1759875977.xml · derivative · entry 3

Silvestro Stephen L · CIK 0001773461 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,649 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F3 · derivative.exercise_date: The restricted stock units vest in three equal annual installments beginning October 3, 2023, the first anniversary of the grant date.

F3 · derivative.expiration_date: The restricted stock units vest in three equal annual installments beginning October 3, 2023, the first anniversary of the grant date.

SEC source: 0001628280-25-044543 · wk-form4_1759875977.xml · nonDerivative · entry 2

Silvestro Stephen L · CIK 0001773461 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 188,916

F2 · shares: These shares were withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended.

SEC source: 0001628280-25-044543 · wk-form4_1759875977.xml · nonDerivative · entry 1

Silvestro Stephen L · CIK 0001773461 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 190,536

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

SEC source: 0001628280-25-044542 · wk-form4_1759875956.xml · derivative · entry 3

Stelmakh Edward · CIK 0001887046 · Chief Finance & Strat Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 16,623 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F3 · derivative.exercise_date: The restricted stock units vest in three equal annual installments beginning October 3, 2023, the first anniversary of the grant date.

F3 · derivative.expiration_date: The restricted stock units vest in three equal annual installments beginning October 3, 2023, the first anniversary of the grant date.

SEC source: 0001628280-25-044542 · wk-form4_1759875956.xml · nonDerivative · entry 2

Stelmakh Edward · CIK 0001887046 · Chief Finance & Strat Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 122,981

F2 · shares: These shares were withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended.

SEC source: 0001628280-25-044542 · wk-form4_1759875956.xml · nonDerivative · entry 1

Stelmakh Edward · CIK 0001887046 · Chief Finance & Strat Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 127,387

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

SEC source: 0001628280-25-050744 · wk-form4_1762555864.xml · nonDerivative · entry 2

D'Silva Andrew J. · CIK 0002083717 · Chief Business Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,306

F1 · shares: These shares were withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended.

SEC source: 0001628280-25-050825 · wk-form4_1762786550.xml · nonDerivative · entry 2

Merrell Brendan W. · CIK 0002090383 · CHIEF OPERATING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,208

F2 · shares: These shares were withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended.

SEC source: 0001628280-25-050744 · wk-form4_1762555864.xml · nonDerivative · entry 1

D'Silva Andrew J. · CIK 0002083717 · Chief Business Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 47,100

F1 · shares: These shares were withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended.

SEC source: 0001296525-25-000002 · wk-form4_1757613304.xml · nonDerivative · entry 1

Spangler Patrick D · CIK 0001296525 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 44,215

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.47 through $18.43. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, complete information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

SEC source: 0001628280-25-041108 · wk-form4_1756149406.xml · derivative · entry 2

Besch Doug · CIK 0001947731 · Chief Prod & Tech Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,156

Underlying: Common Stock · 35,156 shares

Expires 2030-08-21

F2 · derivative.exercise_date: The stock option vests in three equal annual installments beginning August 21, 2026, the first anniversary of the grant date.

SEC source: 0001628280-25-041108 · wk-form4_1756149406.xml · nonDerivative · entry 1

Besch Doug · CIK 0001947731 · Chief Prod & Tech Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 67,230

F1 · balance_after: Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in three equal annual installments beginning on August 21, 2026, which is the first anniversary of the grant date.

SEC source: 0001628280-25-041117 · wk-form4_1756153755.xml · derivative · entry 2

Odence-Ford Marion · CIK 0001845002 · Chief Legal & Admin Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,156

Underlying: Common Stock · 35,156 shares

Expires 2030-08-21

F2 · derivative.exercise_date: The stock option vests in three equal annual installments beginning August 21, 2026, the first anniversary of the grant date.

SEC source: 0001628280-25-041117 · wk-form4_1756153755.xml · nonDerivative · entry 1

Odence-Ford Marion · CIK 0001845002 · Chief Legal & Admin Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 85,901

F1 · balance_after: Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in three equal annual installments beginning on August 21, 2026, which is the first anniversary of the grant date.

SEC source: 0001628280-25-041119 · wk-form4_1756153962.xml · derivative · entry 2

Silvestro Stephen L · CIK 0001773461 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,156

Underlying: Common Stock · 35,156 shares

Expires 2030-08-21

F2 · derivative.exercise_date: The stock option vests in three equal annual installments beginning August 21, 2026, the first anniversary of the grant date.

SEC source: 0001628280-25-041119 · wk-form4_1756153962.xml · nonDerivative · entry 1

Silvestro Stephen L · CIK 0001773461 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 183,887

F1 · balance_after: Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in three equal annual installments beginning on August 21, 2026, which is the first anniversary of the grant date.

SEC source: 0001628280-25-041109 · wk-form4_1756149437.xml · derivative · entry 2

Greco Theresa · CIK 0001998771 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,156

Underlying: Common Stock · 35,156 shares

Expires 2030-08-21

F2 · derivative.exercise_date: The stock option vests in three equal annual installments beginning August 21, 2026, the first anniversary of the grant date.

SEC source: 0001628280-25-041109 · wk-form4_1756149437.xml · nonDerivative · entry 1

Greco Theresa · CIK 0001998771 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 75,981

F1 · balance_after: Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in three equal annual installments beginning on August 21, 2026, which is the first anniversary of the grant date.

SEC source: 0001628280-25-041110 · wk-form4_1756149661.xml · derivative · entry 2

Stelmakh Edward · CIK 0001887046 · CFO/COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,156

Underlying: Common Stock · 35,156 shares

Expires 2030-08-21

F2 · derivative.exercise_date: The stock option vests in three equal annual installments beginning August 21, 2026, the first anniversary of the grant date.

SEC source: 0001628280-25-041110 · wk-form4_1756149661.xml · nonDerivative · entry 1

Stelmakh Edward · CIK 0001887046 · CFO/COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 110,764

F1 · balance_after: Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in three equal annual installments beginning on August 21, 2026, which is the first anniversary of the grant date.

SEC source: 0001628280-25-044426 · wk-form4_1759850764.xml · derivative · entry 2

D'Silva Andrew J. · CIK 0002083717 · Chief Business Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,437

Underlying: Common Stock · 23,437 shares

Expires 2030-08-21

F2 · derivative.exercise_date: The stock option vests in three equal annual installments beginning August 21, 2026, the first anniversary of the grant date.

SEC source: 0001628280-25-044426 · wk-form4_1759850764.xml · nonDerivative · entry 1

D'Silva Andrew J. · CIK 0002083717 · Chief Business Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 47,514

F1 · shares: Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in three equal annual installments beginning on August 21, 2026, which is the first anniversary of the grant date.

SEC source: 0001628280-25-050825 · wk-form4_1762786550.xml · derivative · entry 3

Merrell Brendan W. · CIK 0002090383 · CHIEF OPERATING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,874

Underlying: Common Stock · 23,437 shares

Expires 2030-08-21

F3 · derivative.exercise_date: The stock option vests in three equal annual installments beginning August 21, 2026, the first anniversary of the grant date.

SEC source: 0001628280-25-050825 · wk-form4_1762786550.xml · nonDerivative · entry 1

Merrell Brendan W. · CIK 0002090383 · CHIEF OPERATING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,691

F1 · shares: Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in three equal annual installments beginning on August 21, 2026, which is the first anniversary of the grant date.

SEC source: 0001628280-25-031024 · wk-form4_1749760569.xml · nonDerivative · entry 1

KLEMA CATHY · CIK 0001181157 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,620

F1 · shares: Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in full on the earlier of the first anniversary of the date of the grant or the date of the Company's next annual meeting of shareholders.

SEC source: 0001628280-25-031022 · wk-form4_1749760525.xml · nonDerivative · entry 1

Lang James Paul · CIK 0001703090 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 399,320

F1 · shares: Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in full on the earlier of the first anniversary of the date of the grant or the date of the Company's next annual meeting of shareholders.

SEC source: 0001628280-25-031021 · wk-form4_1749760489.xml · nonDerivative · entry 1

Spangler Patrick D · CIK 0001296525 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 55,335

F1 · shares: Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in full on the earlier of the first anniversary of the date of the grant or the date of the Company's next annual meeting of shareholders.

SEC source: 0001628280-25-031019 · wk-form4_1749760393.xml · nonDerivative · entry 1

Vos Ellen O'Connor · CIK 0001534357 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 72,642

F1 · shares: Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in full on the earlier of the first anniversary of the date of the grant or the date of the Company's next annual meeting of shareholders.

SEC source: 0001628280-25-031015 · wk-form4_1749760310.xml · nonDerivative · entry 1

WASSON GREGORY D · CIK 0001188827 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 57,183

F1 · shares: Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in full on the earlier of the first anniversary of the date of the grant or the date of the Company's next annual meeting of shareholders.

SEC source: 0001628280-25-026500 · wk-form4_1747685039.xml · derivative · entry 3

Greco Theresa · CIK 0001998771 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,133

Underlying: Common Stock · 12,133 shares

Expires 2028-05-15

F3 · derivative.exercise_date: The stock option vests in three equal annual installments beginning May 15, 2026, the first anniversary of the grant date.

SEC source: 0001628280-25-026500 · wk-form4_1747685039.xml · nonDerivative · entry 2

Greco Theresa · CIK 0001998771 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 60,356

F2 · price: Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in three equal annual installments beginning on May 15, 2026, which is the first anniversary of the date of the grant.

SEC source: 0001628280-25-026500 · wk-form4_1747685039.xml · nonDerivative · entry 1

Greco Theresa · CIK 0001998771 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 53,314

F1 · price: Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest on May 15, 2026, which is the anniversary of the date of the grant.

SEC source: 0001628280-25-026499 · wk-form4_1747685005.xml · derivative · entry 2

Silvestro Stephen L · CIK 0001773461 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 80,884

Underlying: Common Stock · 80,884 shares

Expires 2029-05-15

F2 · derivative.exercise_date: The stock option vests in three equal annual installments beginning May 15, 2026, the first anniversary of the grant date.

SEC source: 0001628280-25-026499 · wk-form4_1747685005.xml · nonDerivative · entry 1

Silvestro Stephen L · CIK 0001773461 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 168,262

F1 · price: Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in three equal annual installments beginning on May 15, 2026, which is the first anniversary of the date of grant.

SEC source: 0001628280-25-013918 · wk-form4_1742427618.xml · nonDerivative · entry 1

Lang James Paul · CIK 0001703090 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 389,452

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.18 through $7.80. The reporting person undertakes to provide to the Issuer., any security holder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

SEC source: 0001628280-25-009628 · wk-form4_1741097805.xml · derivative · entry 3

Odence-Ford Marion · CIK 0001845002 · Chief Legal Officer & CHRO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 771 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of OptimizeRx common stock.

F3 · derivative.exercise_date: The restricted stock units vested in three equal annual installments beginning March 1, 2023, the first anniversary of the grant date.

F3 · derivative.expiration_date: The restricted stock units vested in three equal annual installments beginning March 1, 2023, the first anniversary of the grant date.

SEC source: 0001628280-25-009628 · wk-form4_1741097805.xml · nonDerivative · entry 2

Odence-Ford Marion · CIK 0001845002 · Chief Legal Officer & CHRO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 70,276

F2 · shares: These shares were withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended.

SEC source: 0001628280-25-009628 · wk-form4_1741097805.xml · nonDerivative · entry 1

Odence-Ford Marion · CIK 0001845002 · Chief Legal Officer & CHRO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 70,544

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of OptimizeRx common stock.

SEC source: 0001628280-25-009631 · wk-form4_1741097894.xml · derivative · entry 3

Silvestro Stephen L · CIK 0001773461 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,928 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of OptimizeRx common stock.

F3 · derivative.exercise_date: The restricted stock units vested in three equal annual installments beginning March 1, 2023, the first anniversary of the grant date.

F3 · derivative.expiration_date: The restricted stock units vested in three equal annual installments beginning March 1, 2023, the first anniversary of the grant date.

SEC source: 0001628280-25-009631 · wk-form4_1741097894.xml · nonDerivative · entry 2

Silvestro Stephen L · CIK 0001773461 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 121,314

F2 · shares: These shares were withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended.

SEC source: 0001628280-25-009631 · wk-form4_1741097894.xml · nonDerivative · entry 1

Silvestro Stephen L · CIK 0001773461 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 121,886

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of OptimizeRx common stock.

SEC source: 0001628280-25-006690 · wk-form4_1740076778.xml · nonDerivative · entry 1

Besch Doug · CIK 0001947731 · Chief Product Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 51,605

F1 · balance_after: These shares were withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended.

SEC source: 0001628280-25-006687 · wk-form4_1740076725.xml · nonDerivative · entry 1

Odence-Ford Marion · CIK 0001845002 · Chief Legal Officer & CHRO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 69,773

F1 · balance_after: These shares were withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended.

SEC source: 0001628280-25-006689 · wk-form4_1740076754.xml · nonDerivative · entry 1

Silvestro Stephen L · CIK 0001773461 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 119,958

F1 · balance_after: These shares were withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended.